Sadée W - Search Results

1

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Zhang Y, Wang D, Johnson AD, Papp AC, Sadée W. Zhang Y, et al. Among authors: sadee w. J Biol Chem. 2005 Sep 23;280(38):32618-24. doi: 10.1074/jbc.M504942200. Epub 2005 Jul 26. J Biol Chem. 2005. PMID: 16046395 Free article.

2

Differential effects of mu-opioid receptor ligands on Ca(2+) signaling.

Quillan JM, Carlson KW, Song C, Wang D, Sadée W. Quillan JM, et al. Among authors: sadee w. J Pharmacol Exp Ther. 2002 Sep;302(3):1002-12. doi: 10.1124/jpet.302.3.1002. J Pharmacol Exp Ther. 2002. PMID: 12183657

3

Serum response factor activation by muscarinic receptors via RhoA. Novel pathway specific to M1 subtype involving calmodulin, calcineurin, and Pyk2.

Lin K, Wang D, Sadée W. Lin K, et al. Among authors: sadee w. J Biol Chem. 2002 Oct 25;277(43):40789-98. doi: 10.1074/jbc.M202745200. Epub 2002 Aug 27. J Biol Chem. 2002. PMID: 12200418 Free article.

4

Single nucleotide polymorphism genotyping using allele-specific PCR and fluorescence melting curves.

Papp AC, Pinsonneault JK, Cooke G, Sadée W. Papp AC, et al. Among authors: sadee w. Biotechniques. 2003 May;34(5):1068-72. doi: 10.2144/03345dd03. Biotechniques. 2003. PMID: 12765033 Free article.

5

Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.

Wang D, Raehal KM, Lin ET, Lowery JJ, Kieffer BL, Bilsky EJ, Sadée W. Wang D, et al. Among authors: sadee w. J Pharmacol Exp Ther. 2004 Feb;308(2):512-20. doi: 10.1124/jpet.103.054049. Epub 2003 Nov 4. J Pharmacol Exp Ther. 2004. PMID: 14600246

6

Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance.

Huang Y, Anderle P, Bussey KJ, Barbacioru C, Shankavaram U, Dai Z, Reinhold WC, Papp A, Weinstein JN, Sadée W. Huang Y, et al. Among authors: sadee w. Cancer Res. 2004 Jun 15;64(12):4294-301. doi: 10.1158/0008-5472.CAN-03-3884. Cancer Res. 2004. PMID: 15205344

7

Genetic variants of the human H+/dipeptide transporter PEPT2: analysis of haplotype functions.

Pinsonneault J, Nielsen CU, Sadée W. Pinsonneault J, et al. Among authors: sadee w. J Pharmacol Exp Ther. 2004 Dec;311(3):1088-96. doi: 10.1124/jpet.104.073098. Epub 2004 Jul 28. J Pharmacol Exp Ther. 2004. PMID: 15282265

8

Correlating gene expression with chemical scaffolds of cytotoxic agents: ellipticines as substrates and inhibitors of MDR1.

Huang Y, Blower PE, Yang C, Barbacioru C, Dai Z, Zhang Y, Xiao JJ, Chan KK, Sadée W. Huang Y, et al. Among authors: sadee w. Pharmacogenomics J. 2005;5(2):112-25. doi: 10.1038/sj.tpj.6500297. Pharmacogenomics J. 2005. PMID: 15668728

9

Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities.

Sadée W, Wang D, Bilsky EJ. Sadée W, et al. Life Sci. 2005 Feb 11;76(13):1427-37. doi: 10.1016/j.lfs.2004.10.024. Epub 2004 Dec 8. Life Sci. 2005. PMID: 15680308 Review.

10

In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.

Raehal KM, Lowery JJ, Bhamidipati CM, Paolino RM, Blair JR, Wang D, Sadée W, Bilsky EJ. Raehal KM, et al. Among authors: sadee w. J Pharmacol Exp Ther. 2005 Jun;313(3):1150-62. doi: 10.1124/jpet.104.082966. Epub 2005 Feb 16. J Pharmacol Exp Ther. 2005. PMID: 15716384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

365 results

Search Page

Filters